Marc Beer

Marc Beer: The Reason Behind Renovia

Renovia is Marc Beer’s latest biotechnology triumph. He co-founded the company in 2016 in Boston, MA alongside Dr. Ray Iglesias and Yolanda Lorie. Marc Beer is Chairman and CEO of the company, but it was almost not meant to be. If it weren’t a phone call, Beer could’ve still been retired.

Luckily, Beer was ready to come out of retirement, and Dr. Iglesias was close enough to develop a new product line and needed help getting that product line out to the public. Though Beer is leading the company, Renovia would never have happened without Dr. Iglesias’s compassion for his patients.

Dr. Iglesias is a gynecologist who specialized in pelvic floor surgeries simply because there was no other option for women. He always wished there was a product out there that women could rely on before their condition worsened to the point of needing surgery. After 35 years of performing pelvic floor surgeries, Dr. Iglesias took the initiative to create such a product.

After that first phone call, Marc Beer looked into the plausibility of Dr. Iglesias’s business and found that almost one-fourth of American women suffer from pelvic floor disorders. Even more appalling are the ambulatory costs since 2005. Beer immediately recognized pelvic floor disorders as a serious problem and joined Dr. Iglesias in his efforts to provide relief. Learn more:

In Beer’s words, Renovia is trying to develop a successful combination of innovative technologies and a digital health platform. In more understandable terms, Renovia hopes to one day provide first-line diagnosis and treatment through a series of therapeutic and diagnostic devices for women. Pelvic floor disorders, while unknown to most, can cause pelvic organ prolapsed and urinary and fecal incontinence.

In 2018, Renovia made two spectacular steps in the right direction. Firstly, Renovia released its first FDA-approved product, Leva, in April. Secondly, Beer acquired a Series B round of funding from Perceptive Advisors of New York and Ascension Ventures of Missouri. A longtime investor in Renovia, The Longwood Fund, also contributed to the Series B funding Renovia received. The Series B gave Renovia $32 million.

Like with all unknown physical and mental health problems, pelvic floor disorders have a stigma around them. The first step to helping women with these disorders is removing the stigma because the stigma is preventing millions of women from seeking medical advice until it’s too late. That also contributes to why so many women had no other choice but to receive surgery.

Follow Marc Beer on Facebook

The Ups And Downs of Marc Beer’s Career

As the current chairman, cofounder and CEO of Renovia, Marc Beer is certainly no stranger to success but this type of prosperity didn’t always come naturally to him. So how has he managed to rise to the top of the corporate ladder? Well, he recently had a chat with Stephen Callahan where he discussed how he made it this far and what his secrets to success are. From an early age, he knew he wanted to be a businessman so it came as no surprise to anyone when he declared business as his major in college at Miami University. Upon receiving his bachelor of science degree in the spring of 1987, he was offered a position at a company called Abbott where he would serve as a member of their sales development team. He eventually accepted the offer. 

After remaining at the company for over half a decade, he was offered the position of corporate officer by Biostar and he would go on to serve in this role for two years. In the fall of 1996, Genzyme made him an offer that he couldn’t refuse and, before he even knew what was happening, he ended up becoming their vice president of global marketing. Finally, in May of 2000, he resolved to become the founder and CEO of Viacell, a company dedicated to finding as many vaccines and cures to diseases as they possibly can. They did this by extracting stem cells from the umbilical cords of mothers and examining their genetic makeup to find any biomarkers they may be able to use. Learn more:

Under his leadership, the company proved to be lucrative and even employed as many as 300 workers at one point but, just two years after they went public, he decided to sell it for a huge profit. As he began preparing for his next business venture, his plans were put on hold due to the sudden death of his wife, Jennifer, at the age of 42. He had to step up and become the primary caregiver to his three kids and, while that may have worked for a time, he soon realized with the help of his daughter that he needed to get back to the biotech industry. As such, it wasn’t long before he was launching a new company known as Renovia alongside Dr. Ray Iglesias and Yolanda Lorie. As someone who’s invested in it, he has ensured the company’s prosperity. 

Based out of Boston and established in 2016, the company’s sole mission is to develop various medical tools to help patients who are currently battling illnesses. At least one of their products has already been approved by the FDA and they hope to continue this trend.

Follow Marc Beer on Facebook

Carsten Thiel On Working In Biotech

It’s not always easy being one of the leading experts in the field of biochemistry and biotech but, somehow, Carsten Thiel has done a great job of making it look easy. Over the years, there have been many people who wondered about how he manages to do such a good job in all of the projects he has worked on throughout his career.

So he mentioned the Xenical project where he was in charge of promoting this new weight loss drug. As he began working on this marketing campaign, Thiel uncovered a conspiracy that they were attempting to make promises they had no intention of actually keeping. So he counteracted this by modifying the campaign to ensure they maintained the integrity of their product.

Afterward, he was assigned to the Vectibix project. This new assignment entailed promoting the launch of this drug designed to help people who are currently suffering from colorectal cancer. As he was working on this new campaign, he discovered something known as a biomarker located inside this new product.

This typically enables medical professionals to determine whether or not a particular drug would work for each patient depending on their genetic makeup. However, it soon became apparent that these manufacturers had no intention of providing this information to the general public so Carsten Thiel made sure that they informed the consumers of this data before the drugs ended up in supermarkets and pharmacies.

Over the years, he has been praised for his ethics and integrity throughout his career but not many people are sure of how he got where he is today. As a kid, he proved to be an exceptional student and received his bachelor of science degree from the University of Bristol before matriculating at the Max Planck Institute where he would receive his PhD.

An article with Medical Daily Times entitled “Carsten Thiel: Impactful Medicine”, talks about Thiel’s leadership, expertise, professional experience and contribution to the world of Biotechnology.




Marc Beer: Redefining Professionalism in Biotech

In the last two decades, biotech companies have revolutionized how the world views research and innovations. Marc Beer has been part of this growth but through different entities. In more than 25 years, he has actively challenged the prior notion of innovations, especially when creating medical solutions. Currently, Beer is not only a respected figure in this medical space, but he is an important player in women’s reproductive health.

What makes Beer an exceptional expert in women’s reproductive health?

First, he understands issues affecting women — thanks to his connections with gynecologists. In the last 25 years, he has created relationships with other professionals in this space. Marc Beer understands the importance of having an updated reality of a market, as opposed to believing in a static version of a market. Through his interaction with the industry players, he understands that people, especially women with reproductive health complications, require non-invasive procedures. Through his companies, he creates products that answer the clients’ needs without compromising its efficiency.

Second, Beer appreciates the importance of having a good team in a company. In all the years he has been active in this niche, he has been keen on creating management teams that complement his strengths and visions. In his new outfits, Beer is fortunate to have some of the best professionals in different departments. Marc Beer, for example, brought some of the best policymakers to complement his strong research team. He understands that having a strong research team is not enough but having a team that has experts that understand different FDA regulations is critical. Learn more:

Thirdly, he understands that distribution for a company such as Renovia is vital for its existence. Therefore, Marc Beer has embraced all the available avenues in the world of distribution. His main goal is to make all the products accessible to millions of women across the globe. He is, however, also keen on creating distribution channels that help the clients to interact with professionals. Therefore, he uses different ways to make the products from Renovia available to millions of women with reproductive health complications.

Fourthly, in each of the above successes, Beer appreciates the importance of accessing and having funds. Thanks to his social capital and his connections with different stakeholders, he gets the right funding for each project. Marc Beer understands that creating a bond with other stakeholders, especially the financiers, is ideal for his company. As the CEO of his company; therefore, he believes he has the responsibility of protecting the trust investors have on his company.

Finally, his successes in this niche are a reflection of the support given by his family and colleagues. He believes that family and friends have a role to play in his contributions to the medical world.

How Marc Beer has Changed Lives in the World

In the world of medicine, successful private investors are few. People abandon their ventures when they discover the hardships they will face when working in healthcare. Marc Beer, however, has lived his dream career in this complicated industry. After being in healthcare for decades, the investor proved his excellent skills in healthcare by getting so much success. His career in this industry spans more than twenty-five years. Mark Beer has used his knowledge to bring many healthcare companies to success. His secret in marketing is developing effective solutions that can solve pressing and immediate problems in healthcare. The American born investor has a Bachelor of Science focusing on business. This degree, according to his portfolio, is from the popular Miami University.

Mark Beer completed his university education in the year 1987. The entrepreneur realized that he was talented in business, and he was very passionate about pharmaceutical activities. His first working position was the role of vice president in a company that is popular in the global arena. Genzyme registered so much growth when Mark Beer joined many years ago. The product line, for instance, managed to shock the international competitors. His team served more than three hundred and fifty million patients around the world. In the past, these individuals could not access the treatment they needed because they had rare forms of diseases.

When dealing with the underserved people in the global market, Marc Beer discovered that with a little effort, it was possible for him to conquer the market and reach more people. All he needed was to put more commitment to his game. Pushing further to make a difference in the world worked so well. His focus remained in the pharmaceutical industry, where he was most experienced. The businessperson set up his first company with the hope of getting more people treated from dangerous diseases. The company launched successfully in the market.

In the year 2007, VIA CELL was the pharmaceutical company making headlines all over the entire world. The founder of this institution, Marc Beer, was the topic in the medical industry. Having served in a global company, Marc Beer knew a lot about sales and marketing in the pharmaceutical section. The company touched many lives during its operational years. The primary aim of the institution was collecting and at the same time, preserving umbilical cord stem cells. This treatment could later cure a wide range of conditions affecting the human body. This kind of therapy was rare in the international market, and everyone wanted to try it. Fortunately, it worked for so many people who lived miserable lives of pain. In return, Marc Beer’s company grew and increased its presence in the pharmaceutical world. The executive was excited that he met his goal in his career. Learn more:

Marc Beer Is The Newest Board Chairman Of LumeNXT

With his experience in the pharmaceutical and biotechnology industry, Marc Beer is one of the best professionals in both fields. Sporting a brilliant track in his 25 years of being in the professional scene, Beer is one of the most successful and most recognized names in the industry. Earlier this year, he once again received another recognition when LumeNXT, a company that manufactures surgical illumination tools, named him as the newest Board Chairman of the company.


Marc Beer reacted to this and revealed that he is proud that he has been trusted to the position. This also excites him because he will have a chance to join and work with accomplished surgeons and engineers who developed the products of LumeNXT. In addition to this, he believes that the company will play an important role in the future, especially that the minimally invasive methods are becoming more and more popular to surgeons and medical practitioners. As this method takes over the world of medicine, Beer believes that LumeNXT will be able to aid medical professionals and give a better result.


LumeNXT is known for its illumination products which utilize proprietary technology to enhance the visualization of the operation. This enhances precision and flexibility in the operation, which is important to minimize any risk of failure. What makes the products of LumeNXT special is that it creates bright light that delivers enhanced visibility generating a lot of heat which instead makes the operation more difficult. In addition, the products of the company are targeted to be a low-cost and disposable option without compromising the quality of the output.


The Co-Founder of LumeNXT, Paul Rhyme, expressed his trust to Marc Beer, who has been veteran in the field. Rhyme knows that Beer has been handling pharmaceutical startups ever since the start of his career and is known for making the companies he handle successful and profitable. Rhyme also believes that through Beer’s help, LumeNXT will be able to achieve more growth and commercial success to its future rollout. Beer created a lot of companies in the past which he was able to grow and sell for profitable prices.


Right now, Marc Beer is also one of the key executives of Renovia, a company dedicated to creating products that aim to diagnose and treat Pelvic Floor Disorders for women. It is currently developing four products for the purpose of diagnosis and therapy and uses revolutionary technology. Beer co-founded Renovia in 2016 and serves as the chief executive officer and was able to raise a $42 million fund for Renovia’s product development. Among the other companies that he founded is Minerva Neurosciences Inc., which aims to develop treatments for central nervous system diseases. Beer graduated from Miami University  Learn more: